Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Integrated multidisciplinary care pathway for optimising secondary prevention lipid modification therapy in people with established cardiovascular disease - six-month interim analysis

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: HPS-103
  • By: HAMEDI, Nadya (Barts Health NHS Trust, United Kingdom)
  • Co-author(s): Ms Nadya Hamedi, Cardiac Pharmacist (Barts Health NHS Trust, London, United Kingdom)
    Mr Mital Patel, Pharmacy (Barts Health NHS Trust, London, United Kingdom)
    Ms Shabana Ali (Southdene Surgery, London, United Kingdom)
    Mr John Robson (Clinical Effectiveness Group Queen Mary University of London, United Kingdom)
    Mr Riyaz Patel, Cardiology (Barts Health NHS Trust, London, United Kingdom)
    Mr Harry Albert (UCLPartners, London, United Kingdom)
    Mr Imran Khan, Pharmacy (Redbridge CCG, London, United Kingdom)
    Mr Matt Kearney (UCLPartners, London, United Kingdom)
    Dr Belinda Krishek (Redbridge CCG, London, United Kingdom)
    Mr Sadeer Fhadil, Pharmacy (Barts Health NHS Trust, London, United Kingdom)
    Mr Paul Wright, Pharmacy (Barts Health NHS Trust, London, United Kingdom)
    Mr Sotiris Antoniou, Pharmacy (Barts Health NHS Trust, London, United Kingdom)
  • Abstract:

    Introduction

    Cardiovascular disease (CVD) is a leading cause of mortality worldwide and accounts for approximately 27% of all deaths in United Kingdom (UK). It is also estimated that 7.7 million people in the UK are living with CVD and it is costing the economy £19 billion every year.

    The relationship of hypercholestrolaemia to CVD is well..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses